JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Batrakova, E. V.
Right arrow Articles by Kabanov, A. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Batrakova, E. V.
Right arrow Articles by Kabanov, A. V.

NEUROPHARMACOLOGY

Optimal Structure Requirements for Pluronic Block Copolymers in Modifying P-glycoprotein Drug Efflux Transporter Activity in Bovine Brain Microvessel Endothelial Cells

Elena V. Batrakova, Shu Li, Valery Yu Alakhov, Donald W. Miller, and Alexander V. Kabanov

Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, Nebraska (E.V.K., S.L., S.V.V., D.W.M., A.V.K.); and Supratek Pharma Inc., Laval, Quebec, Canada (V.Y.A.)

Pluronic block copolymer P85 was shown to inhibit the P-glycoprotein (Pgp) drug efflux system and to increase the permeability of a broad spectrum of drugs in the blood-brain barrier (BBB). However, there is an entire series of Pluronics varying in lengths of propylene oxide and ethylene oxide and overall lipophilicity. This study identifies those structural characteristics of Pluronics required for maximal impact on drug efflux transporter activity in bovine brain microvessel endothelial cells (BBMECs). Using a wide range of block copolymers, differing in hydrophilic-lipophilic balance (HLB), this study shows that lipophilic Pluronics with intermediate length of propylene oxide block (from 30 to 60 units) and HLB <20 are the most effective at inhibiting Pgp efflux in BBMECs. The methods used included 1) cellular accumulation studies with the Pgp substrate rhodamine 123 in BBMECs to assess Pgp activity; 2) luciferin/luciferase ATP assay to evaluate changes in cellular ATP; 3) 1,6-diphenyl-1,3,5-hexatriene membrane microviscosity studies to determine alterations in membrane fluidity; and 4) Pgp ATPase assays using human Pgp-expressing membranes. Pluronics with intermediate lipophilic properties showed the strongest fluidization effect on the cell membranes along with the most efficient reduction of intracellular ATP synthesis in BBMEC monolayers. The relationship between the structure of Pluronic block copolymers and their biological response-modifying effects in BBMECs are useful for determining formulations with maximal efficacy for increasing BBB permeability.


Received August 27, 2002; accepted October 14, 2002.

Address correspondence to: Dr. Alexander V. Kabanov, Department of Pharmaceutical Sciences, University of Nebraska Medical Center, 986025 Nebraska Medical Center, Omaha, NE 68198-6025. E-mail: akabanov{at}unmc.edu




This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
M. Bello-Roufai, O. Lambert, and B. Pitard
Relationships between the physicochemical properties of an amphiphilic triblock copolymers/DNA complexes and their intramuscular transfection efficiency
Nucleic Acids Res., February 16, 2007; 35(3): 728 - 739.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
S. M. Moghimi, A. C. Hunter, and J. C. Murray
Nanomedicine: current status and future prospects
FASEB J, March 1, 2005; 19(3): 311 - 330.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. S. Jakate, C. M. Einhaus, A. P. DeAnglis, G. S. Retzinger, and P. B. Desai
Preparation, Characterization, and Preliminary Application of Fibrinogen-Coated Olive Oil Droplets for the Targeted Delivery of Docetaxel to Solid Malignancies
Cancer Res., November 1, 2003; 63(21): 7314 - 7320.
[Abstract] [Full Text] [PDF]


Home page
Journal of Bioactive and Compatible PolymersHome page
C. L. Gebhart and A. V. Kabanov
Perspectives on Polymeric Gene Delivery
Journal of Bioactive and Compatible Polymers, March 1, 2003; 18(2): 147 - 166.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics.